MedTrace Logo

Evaluation of Accuracy of Guardian Sensor 3 in Diabetes Patients on Peritoneal Dialysis

NCT04776811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-11-28

No results posted yet for this study

Summary

Assessment of performance (precision and accuracy) of Guardian Sensor™ 3 as compared with a gold standard reference laboratory method (YSI glucose) in diabetes patients on peritoneal dialysis.

Conditions

Interventions

DEVICE

Continuous glucose monitoring system

Medtronic Guardian Connect with Guardian Sensor 3

Sponsors & Collaborators

  • Medtronic Diabetes

    collaborator INDUSTRY

  • Elaine Chow

    lead OTHER

Principal Investigators

  • Elaine Chow, PhD, MBChB · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04776811 on ClinicalTrials.gov